abstract |
The present invention relates to a monoclonal antibody that specifically binds to a cell surface protein of human embryonic stem cells and a hybridoma that produces the same. More specifically, the present invention relates to a monoclonal antibody that specifically binds to cell surface proteins of human embryonic stem cells, A monoclonal antibody that does not bind to stem cells, a hybridoma that produces the monoclonal antibody, a black kit comprising the monoclonal antibody, and a composition for removing human embryonic stem cells. |